Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Estimated operating results in the first half of 2024.pdfEstimated operating results for the first half of 2024

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 31 / 2024
Date of issue: 2024-07-11
Short name of the issuer
KRKA
Subject
Information regarding estimated operating results of the Krka Group for the first half of 2024
Official market - legal basis
art. 17. 1 MAR.
Unofficial market - legal basis
Contents of the report:
ased on Article 17 of Regulation (EU) no. 596/2014 company Krka, d. d., Novo mesto releases information regarding estimated operating results of the Krka Group for the first half of 2024.

See attached document.


The notice will be published on the Company's website (www.krka.biz) from 11 July 2024 onwards, for a period of at least 5 years.
Annexes
File Description
Estimated operating results in the first half of 2024.pdf
Estimated operating results in the first half of 2024.pdf		 Estimated operating results for the first half of 2024

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2024-07-11 Jože Colarič President of the Management Board and CEO
20240711_132113_0306642347_Estimated_operating_results_in_the_first_half_of_2024.pdf

Pobierz